Squid studies illuminate neural dysfunction in ALS; suggest new route to therapy

Squid studies suggest new route to therapy for ALS, targeting synaptic dysfunction

Squid studies suggest new route to therapy for ALS, targeting synaptic dysfunction

Squid studies suggest new route to therapy for ALS, targeting synaptic dysfunction

Squid studies illuminate neural dysfunction in ALS; suggest new route to therapy
A catch of the longfin inshore squid (Doryteuthis pealeii) aboard the collecting boat of the Marine Biological Laboratory, The Gemma. This species has been used for basic research in neuroscience since the 1930s. Credit: Daniel Cojanu

Amyotrophic lateral sclerosis (ALS) is one of the most devastating adult-onset neurodegenerative diseases. Patients, including the late actor/playwright Sam Shepard, become progressively weaker and eventually paralyzed as their motor neurons degenerate and die.

To find a cure for ALS, which is fatal, scientists need a deeper understanding of how it interrupts motor neuron communication channels. Because motor neurons reach from the brain to the spinal cord, and from the spinal cord to the muscles, when they die, the brain can no longer initiate muscle movement.

Yuyu Song of Harvard Medical School was a Grass Fellow at the Marine Biological Laboratory (MBL), Woods Hole, when she took advantage of a powerful research organism in neuroscience, the local squid, to start asking how a mutant protein associated with familial ALS behaves under controlled conditions.

Her study, recently published in eNeuro, clarifies the mechanisms underlying neural dysfunction in ALS, and also suggests a novel approach to restoring the health of motor neurons in patients with the disease.

Song focused on how this mutant protein, called G85R-SOD1, affects neurotransmission at the squid “giant synapse,” the junction where neurons transmit chemical signals to muscle fibers, causing the muscle to contract.

Squid studies illuminate neural dysfunction in ALS; suggest new route to therapy
Yuyu Song at the Marine Biological Laboratory. Credit: Yuyu Song.

The squid giant synapse is one of the few mature nervous systems that mimics human neuromuscular junctions, while allowing precise experimental manipulations and live measurements.

Song showed that the presence of misfolded mutant SOD1 inhibits synaptic transmission and diminishes the pool of synaptic vesicles, whose job is to deliver neurotransmitters critical for neuronal connections.

Surprisingly, synaptic function was restored by intermittent, high-frequency stimulation, which suggested aberrant calcium signaling may underlie SOD1 toxicity to normal synaptic transmission.

To test this hypothesis, Song used calcium imaging to capture the abnormal calcium influx in the presynaptic terminal and confirmed the protective role of a calcium chelator, which corrected the calcium imbalance without affecting neurotransmission.

This suggests a new approach to therapeutic intervention for ALS, in which chemical or electrical regulation of calcium and its downstream signaling pathways may restore the health of motor neurons.

“Altogether, our results not only demonstrated synaptic dysfunction related to ALS and its underlying molecular pathways, but also extended our understanding of fundamental synaptic physiology,” Song says.

Song, who is an MD-PhD, has spent numerous summers at the MBL using the local squid to unravel the basic pathologies underlying neurodegenerative disease. She started coming regularly in 2007 as a graduate student with Scott Brady, whose lab was developing the squid’s giant axon (nerve fiber) as a system for studying human disease.

“One summer, I chatted with Rodolfo Linas at the MBL, who has been doing synaptic recordings in the squid for many decades,” Song says. “I helped his lab with some electron microscopy on the squid giant synapse together with Jorge Moreira, and Rodolfo challenged/encouraged me to do synaptic studies myself. In the summer of 2013, I decided to establish the squid giant synapse as a disease model for ALS and to learn electrophysiology in this classical preparation.”

That same summer, Song met Whitman Center scientists Steve Zottoli, George Augustine and Len Kaczmarek, who advised her to apply for a Grass Fellowship, in which she could set up an independent research project at MBL. After her productive Grass Lab experience, Song returned to the MBL for several years as a Whitman Center scientist and initiated further collaborations with MBL and University of Chicago scientists.

Song found an enduring family at the MBL, she says. “The 2014 Grass Fellows are still in touch with one another and we share our success and struggle in life and science together,” she says. The Grass Lab’s directors and administrators remain dear friends. And she is quick to acknowledge the essential contribution of the MBL’s collecting operation, which provides a daily catch of squid to her and other MBL scientists in season. “All the crew in the Marine Resources Center feel like family, not just scientific collaborators,” she says.


Restoring nerve-muscle communication in ALS


More information:
Yuyu Song, Synaptic Actions of Amyotrophic Lateral Sclerosis-Associated G85R-SOD1 in the Squid Giant Synapse, eNeuro (2020). DOI: 10.1523/ENEURO.0369-19.2020

Citation:
Squid studies suggest new route to therapy for ALS, targeting synaptic dysfunction (2020, June 1)
retrieved 1 June 2020
from https://medicalxpress.com/news/2020-06-squid-route-therapy-als-synaptic.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.


https://medicalxpress.com/news/2020-06-squid-route-therapy-als-synaptic.html

Check Also

covid-19

US records 43,742 new virus cases in 24 hours: tracker

US records 43,742 new virus cases in 24 hours: tracker US records 43,742 new virus …